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Background. Delays in postpartum contraceptive use may increase risk for unintended or rapid repeat pregnancies. The postpartum
care visit (PPCV) is a good opportunity for women to discuss family planning options with their health care providers. This study
examined the association between PPCV attendance and modern contraceptive use using data from a managed care organization.
Methods. Claims and demographic and administrative data came from a nonprofit managed care organization in Virginia (2008–
2012). Information on the most recent delivery for mothers with singleton births was analyzed (N = 24,619). Routine PPCV (yes,
no) and modern contraceptive use were both dichotomized. Descriptive analyses provided percentages, frequencies, and means.
Multiple logistic regression was conducted and ORs and 95% CIs were calculated. Results. More than half of the women did not
attend their PPCV (50.8%) and 86.9% had no modern contraceptive use. After controlling for the effects of confounders, women
with PPCV were 50% more likely to use modern contraceptive methods than women with no PPCV (OR = 1.50, 95% CI = 1.31,
1.72). Conclusions. These findings highlight the importance of PPCV in improving modern contraceptive use and guide health care
policy in the effort of reducing unintended pregnancy rates.

1. Introduction
Unintended pregnancy is a major public health problem in
the US. According to a recent study analyzing data from the
National Survey of Family Growth, in 2008, over half (51%)
of the 6.6 million pregnancies in the US were unintended
[1]. Additionally, a report using data from the National
Survey of Family Growth that compared the proportion of
US unintended pregnancies between 1982 and 2006–2010
found no significant improvements in the rates of unintended
pregnancies over this extended time period [2]. Moreover,

despite the availability of effective modern contraceptive
methods, the rate of unintended pregnancies increased from
48% in 2001 to 51% in 2008 [1].
Unintended pregnancies are major public health concerns with potential detrimental effects on the health and
wellbeing of infants, mothers, and society as a whole. Unintended pregnancy is associated with delayed prenatal care,
smoking or drinking during pregnancy, preterm birth and
low birth weight, poor attitudes towards parenting, poor
infant development, and poor mother-infant relationships
[3–6]. These levy a heavy burden on both state and federal
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economies. For instance, in 2010, total government expenditures on unintended pregnancies amounted to $21.0 billion,
accounting for more than half of the $40.8 billion spent on all
publicly funded pregnancies in 2010 [7].
Most women and couples want to have control over the
timing and spacing of their childbearing for both economic
and social reasons [8, 9]. The postpartum care visit (PPCV)
is a good opportunity for patients and their significant others
to have important conversations about family planning with
their health care providers. The PPCV also allows providers
to give necessary counseling and resources to women. Fundamentally, the best way of preventing unintended pregnancies
is to provide women with an effective modern contraceptive
method, which can be done through contraceptive counseling at a routine PPCV.
Delays in postpartum contraceptive use create a risky
environment for women to have unintended or rapid repeat
pregnancies [10, 11]. Although ovulation can occur within six
weeks after delivery, it can occur as early as four weeks in
nonbreastfeeding women [11]. Therefore, providing women
with modern contraceptive methods shortly after they give
birth is an effective way of curtailing the risk of an unintended
pregnancy.
Some studies have shown the beneficial impact of PPCV
attendance on greater contraceptive use [12–14] and reduced
likelihood of rapid repeat pregnancy [15, 16] in select subgroups of women. Even women with no insurance or Medicaid were found to increase their use of an effective method
after delivery if they attended counseling sessions [14].
However, the results did not account for important factors
that could have affected postnatal services such as substance
use or mental health problems (e.g., depression). Moreover,
receipt of counseling was based on self-report data and did
not necessarily indicate PPCV compliance or attendance. The
fact remains that the PPCV is part of the standards of care for
postpartum women and presents a suitable opportunity for
contraceptive counseling. Strategies designed to reduce high
rates of unintended pregnancies would benefit from targeting
the postpartum period since women’s opinions of subsequent
pregnancies change over time [10].
The purpose of this study is to examine the association between PPCV attendance and the use of modern
contraceptives among women who received care from a
nonprofit managed care organization in the state of Virginia.
These findings could provide a better understanding of the
influence of the PPCV on modern contraceptive use and
guide health care policy in the effort of reducing unintended
pregnancy rates.

2. Materials and Methods
Data came from Virginia Premier, a managed care organization that coordinates health care services for low-income
individuals enrolled in Virginia Medicaid. Claims and demographic and administrative information were available for
women with singleton births between the years of 2008 to
2012. Information on the most recent birth was analyzed
for mothers who gave birth to more than one infant during
the study period. Thus, the total sample size was comprised
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of 24,619 women. This study was approved by the Virginia
Commonwealth University Institutional Review Board.
The demographic dataset included information on maternal characteristics such as age, race, and region of residence.
The birth event dataset included birthing information, such
as delivery date, delivery type (vaginal, C-section), gestational
age, and birth weight of infant, as well as NICU status and
length of stay. Medical claims data were also included and
provided the International Classification of Diseases, Ninth
Revision (ICD-9) codes used to determine postpartum visit
attendance, pregnancy complications, and substance abuse.
Additionally, interview data was collected by case managers
during both prenatal and postpartum period for clinical
administrative purposes. These consisted of personal information such as education level, primary language spoken,
smoking status, alcohol use, breastfeeding intention during
pregnancy and actual feeding method (i.e., breastfeeding,
bottle feeding, or both), depression, and birth control use, as
well as the instances and types of case management.
The exposure of interest, PPCV attendance, came from
medical claims data containing ICD-9-Clinical Modification
(ICD-9-CM) for medical diagnoses and procedures on claims
for services. Postpartum care and evaluation at the follow-up
visit were determined by an ICD-9 code for routine postpartum follow-up (V24.2). This information was categorized as
“yes” or “no.”
The outcome, modern contraceptive use, came from
the interview data which were collected by case managers
for clinical administrative purposes. Women who reported
using any modern contraceptive methods such as “birth
control pill,” “Depo-Provera,” “Norplant,” “patch,” “ring,”
“IUD” (i.e., intrauterine device), “condoms and foam,” and
“diaphragm” were classified as “users.” Those who did not
indicate the use of any methods were considered “nonusers.”
Sociodemographic factors included maternal age (≤20
years; 21–29 years; ≥30 years), race/ethnicity (White; Black;
Hispanic; other), and the highest educational level (less than
high school; high school graduate; greater than high school).
Maternal region of residence in Virginia was categorized
into seven regions: Danville/Lynchburg, Far Southwest, Fredericksburg, Richmond, Roanoke, Tidewater, and Western.
Location of the majority of medical services was defined
as the type of health care system most utilized by each
individual patient (private office; hospital; health department;
or federally qualified health centers (FQHC)). This was based
on the total number of visits to each health care setting
calculated for each woman. Substance use and mental health
problems included tobacco use disorder (yes, no), drug
abuse/dependence (yes, no), alcohol abuse/dependence (yes,
no), and history of depression (yes, no). Pregnancy complications including preeclampsia, eclampsia, hypertension,
diabetes, anemia, cervical incompetence, ectopic pregnancy,
uterine inertia, premature separation of placenta, and placenta previa (yes; no), type of delivery (normal vaginal,
caesarean section), and birth outcomes (normal weight and
term; normal weight and preterm; low birth weight and term;
low birth weight and preterm), where preterm birth was
defined as gestational age of <37 weeks and low birth weight
was defined as <2500 grams, were also assessed.
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Descriptive analyses were conducted and percentages,
frequencies, and means were reported. Bivariate analysis was
conducted to examine factors associated with attending a
PPCV or modern contraceptive use. To adjust for potential
confounders, multivariable logistic regression was conducted
and odds ratios (OR) and 95% confidence intervals (CIs)
were calculated. Potential confounders were identified and
included in the model if the variable resulted in a 10% or
greater change in the estimate.

3. Results
The average age of the study population was 24.9 (standard
deviation = 5.3) years. The majority of the women were 21–29
years of age (59.8%), had high school education (51.4), used
hospitals for the majority of their medical services (87.3%),
had normal vaginal deliveries (67.8%), and delivered their
babies at normal weight and term (86.7%) (Table 1). Nearly
half (49.3%) of the women attended their postpartum visit
and 86.9% had no recorded modern contraceptive use.
Factors associated with modern contraceptive use
included sociodemographic factors (i.e., age, race, location
of majority of services, and region of residence in Virginia;
𝑝 < 0.0001), health behavioral factors (i.e., tobacco use, 𝑝 =
0.0010; drug abuse/dependence, 𝑝 = 0.0140), and pregnancy
complications (𝑝 = 0.0202). Specifically, modern contraceptive users included a greater proportion of women who were
aged 20 years or younger and Black or Hispanic. Importantly,
a greater proportion of modern contraceptive users
attended their PPCV (57.1%) compared to nonusers (48.1%,
𝑝 < 0.0001). Moreover, there was a significant difference in
the distribution of region of residence for women who used
modern contraceptives and those who did not. Specifically,
a greater proportion of women who used contraception
resided in highly populated urban regions than women
who did not use contraception (Richmond, 17.4% versus
14.3%; Roanoke, 31.1% versus 28.8%). A greater proportion
of nonusers resided in regions with smaller populations than
women who used contraception (Danville/Lynchburg, 10.3%
versus 8.8%; Fredericksburg, 6.8% versus 6.1%).
More than half of the women who were ≤20 years of
age (50.0%), Black (50.9%), and highly educated (54.9%)
attended their postpartum visits (Table 2). Women who
received most of their medical services from a hospital or
health department/FQHC had significantly increased odds of
attending their postpartum visits than women who utilized
mostly health services from private offices (COR [crude odds
ratio] = 1.36, 95% CI = 1.24–1.50; COR = 1.99, 95% CI =
1.72–2.30, resp.). Likewise, compared to women from Fredericksburg, those who lived in areas with greater poverty
were more likely to attend their postpartum visit, for example, Danville/Lynchburg, Western, and Richmond. In fact,
women from Danville/Lynchburg were nearly three times as
likely to attend postpartum visits (COR = 3.32, 95% CI = 2.92–
3.79). Additionally, women with a history of depression were
more likely to attend their postpartum visits when compared
with women with no history of depression (COR = 1.13, 95%
CI = 1.02–1.24). In terms of health behavioral factors, tobacco
users and those diagnosed with drug abuse/dependence were
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less likely to attend their postpartum visits than nonusers
and women not diagnosed with drug abuse/dependence
(OR = 0.83, 95% CI = 0.78–0.88; OR = 0.67, 95% CI =
0.60–0.74, resp.). Women who experienced pregnancy complications had 1.23 times the odds of attending their postpartum visit compared with women with no complications
during pregnancy (COR = 1.23, 95% CI = 1.17–1.30). There
were no significant differences in postpartum visit attendance between women with normal vaginal delivery and
women with C-sections. Moreover, when considering birth
outcomes, women who delivered infants that were both of
low birth weight and preterm were significantly less likely
to attend their postpartum visit than women who delivered
infants that were of normal weight and term (Table 2).
A significant association between postpartum visit attendance and modern contraceptive use was observed (Table 3).
Women who attended their postpartum visit were 44%
more likely to use postpartum contraception compared to
women with no postpartum visit (OR = 1.44, 95% CI = 1.33–
1.55). No covariate changed the estimate by 10% or greater;
therefore, the unadjusted model was retained. Nonetheless, estimates remained robust and statistically significant
even after controlling for age, race, education, location
of majority of services, region of residence, tobacco use,
drug abuse/dependence, alcohol abuse/dependence, history
of depression, pregnancy complications, method of delivery,
and birth outcomes (AOR [adjusted odds ratio] = 1.50, 95%
CI = 1.31–1.72). In other words, women attending postpartum
visits were 50% more likely to use modern contraceptive
methods than women who did not attend their postpartum
visit (Table 3).

4. Discussion
Despite the majority of the study population having no
postpartum modern contraceptive use, women were 50%
more likely to use contraception after delivery if they attended
a postpartum appointment compared to those who did not
attend their PPCV. This was independent of sociodemographic factors, substance use, depression, and pregnancy or
birth complications.
Findings from the current study suggest that the period
following childbirth is a crucial and opportune time for new
mothers receiving publicly funded health care services to
get insurance coverage for contraception and counseling and
guidance on effective methods to avoid unintended and rapid
repeat pregnancy [17, 18]. For example, Thiel de Bocanegra
et al. examined health records for Medicaid recipients in
California (n = 117,644) and reported that although only
41% had a modern contraceptive claim within 90 days of
giving birth, receipt of contraception at the first postpartum
clinic visit was significantly associated with avoiding another
pregnancy within 6 and 18 months of a previous live birth
(AOR = 1.63, 95% CI = 1.49, 1.80; AOR = 1.57, 95% CI = 1.50,
1.65, resp.) [17]. Recognizing the importance of postpartum
care, the American Academy of Pediatrics and the American
College of Obstetricians and Gynecologists recommend that
new mothers have a checkup four to six weeks after delivery
[19].
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Table 1: Distribution of population characteristics by postpartum contraceptive use.
Contraceptive use
Yes
No
N = 3,232
N = 21,387

Total population
N = 24,619

𝜒2

𝑝 value

84.43

<0.0001

52.49

<0.0001

0.90

0.6388

23.32

<0.0001

107.36

<0.0001

10.88
6.04
0.08
2.12
5.39
2.11

0.0010
0.0140
0.7831
0.1454
0.0202
0.1463

6.79

0.0787

91.28

<0.0001

Column %
Age
≤20 years
21–29 years
≥30 years
Race
White
Black
Hispanic
Other
Education
<High school
High school
>High school
Location of majority of services
Private
Hospital
Health department/FQHC
Region of residence in Virginia
Danville/Lynchburg
Far Southwest
Fredericksburg
Richmond
Roanoke
Tidewater
Western
Tobacco use
Drug abuse/dependence
Alcohol abuse/dependence
History of depression
Pregnancy complications
Delivery
Normal vaginal
C-section
Birth outcomes
Normal weight & term
Normal weight & preterm
Low birth weight & term
Low birth weight & preterm
Postpartum visit attendance
Yes
No

26.1
61.2
12.7

21.6
59.6
18.8

22.2
59.8
18.0

51.6
28.3
5.6
14.5

56.2
25.1
3.0
15.7

55.7
25.5
3.3
15.5

19.2
50.9
29.9

19.4
51.8
28.8

19.3
51.4
29.3

5.9
89.9
4.3

7.9
86.9
5.2

7.7
87.3
5.1

8.8
0.9
6.1
17.4
31.1
17.4
18.3
24.7
5.0
1.0
7.3
42.4

10.3
3.9
6.8
14.3
28.8
18.6
17.4
27.5
6.1
1.0
6.6
40.3

10.1
3.5
6.7
14.7
29.1
18.4
17.5
27.1
6.0
1.0
6.7
40.6

68.9
31.1

67.6
32.4

67.8
32.2

88.1
3.3
3.2
5.5

86.5
3.9
3.6
6.0

86.7
3.9
3.6
5.9

57.1
42.9

48.1
51.9

49.3
50.8

FQHC: federally qualified health centers; g: grams; wks: weeks. Normal weight: ≥2500 grams; low birth weight: <2500 grams; term: ≥37 weeks; preterm: <37
weeks.
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Table 2: Factors associated with postpartum visit attendance.

Age
≤20 years
21–29 years
≥30 years
Race
White
Black
Hispanic
Other
Education
<High school
High school
>High school
Location of majority of services
Private
Hospital
Health department/FQHC
Region of residence in Virginia
Danville/Lynchburg
Far Southwest
Fredericksburg
Richmond
Roanoke
Tidewater
Western
Tobacco use
No
Yes
Drug abuse/dependence
No
Yes
Alcohol abuse/dependence
No
Yes
History of depression
No
Yes
Pregnancy complications
No
Yes
Delivery
Normal vaginal
C-section
Birth outcomes
Normal weight & term
Normal weight & preterm
Low birth weight & term
Low birth weight & preterm

Postpartum visit (row %)

Crude OR (95% CI)

50.0
49.4
48.0

1.00
0.97 (0.92–1.04)
0.92 (0.85–1.00)

49.6
50.9
48.7
48.9

1.00
1.05 (0.98–1.13)
0.97 (0.82–1.16)
0.97 (0.88–1.05)

51.8
54.3
54.9

0.88 (0.76–1.03)
0.98 (0.87–1.10)
1.00

41.9
49.5
58.9

1.00
1.36 (1.24–1.50)∗
1.99 (1.72–2.30)∗

70.2
48.6
41.5
49.4
45.0
42.8
54.1

3.32 (2.92–3.79)∗
1.33 (1.13–1.57)∗
1.00
1.38 (1.23–1.55)∗
1.16 (1.04–1.29)
1.05 (0.94–1.18)
1.66 (1.48–1.86)

50.5
45.8

1.00
0.83 (0.78–0.88)

49.9
39.9

1.00
0.67 (0.60–0.74)

49.3
44.7

1.00
0.83 (0.65–1.07)

49.1
52.0

1.00
1.13 (1.02–1.24)

47.2
52.3

1.00
1.23 (1.17–1.30)

49.3
49.4

1.00
1.00 (0.95–1.06)

49.6
49.8
46.8
45.7

1.00
1.01 (0.89–1.15)
0.89 (0.78–1.02)
0.86 (0.77–0.95)

OR: odds ratio; CI: confidence interval; FQHC: federally qualified health centers; g: grams; wks: weeks. Normal weight: ≥2500 grams; low birth weight: <2500
grams; term: ≥37 weeks; preterm: <37 weeks. ∗ 𝑝 < 0.05.
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Table 3: Association between postpartum visit attendance and
contraceptive use.
a

Postpartum visit
No postpartum visit

∗

OR (95% CI)
1.44 (1.33–1.55)
1.00

b
∗

OR (95% CI)
1.50 (1.31–1.72)
1.00

OR: odds ratio; CI: confidence interval.
a
No factor changed the estimate by 10% or greater.
b
Fully adjusted model controlling for age, race, education, location of majority of services, region of residence, tobacco use, drug abuse/dependence,
alcohol abuse/dependence, history of depression, pregnancy complications,
delivery, and birth outcomes.
∗
Statistically significant.

health care services can provide more useful information on
areas to improve in health care delivery and intervention
efforts. Nonetheless, there were some study limitations. The
dataset did not contain information on the quality of patientprovider interaction during PPCVs (e.g., topics covered,
duration of visit, and communication style) that would
be better assessed in qualitative studies [23]. Additionally,
confounding factors such as breastfeeding were not assessed
due to lack of complete data. We were also unable to ascertain
whether certain modern contraceptive methods that were
claimed under the insurance (e.g., birth control pills, barrier
methods) were actually used.

5. Conclusions
Extant literature supports the results from our study
in that patients who do not attend their PPCV are less
likely to use contraception or effective methods (e.g., longacting reversible contraception or LARC) [12–17, 20, 21]. For
instance, DePiñeres et al. examined factors associated with
postpartum contraception using self-report data from New
Mexico PRAMS (1998-1999). Women aged 35 years or more,
unmarried and lacking a postpartum visit, had increased
risk of no postpartum contraception [21]. Specifically, the
odds of postpartum modern contraceptive use were nearly
threefold greater in women who reported attending their
PPCV than in those who did not attend (AOR = 3.06, 95%
CI = 2.17, 4.31) [21]. Likewise, a recent study that assessed
women’s barriers to receiving LARC in the postpartum period
reported common reasons for nonuse being having to come
back for another insertion visit (45%) and being unable to
afford LARC methods (11%) [20]. Moreover, women who
were interested in but not using LARC were more likely to
have missed their postpartum visit compared to women using
effective methods (𝑝 = 0.001) [20]. This can be especially
problematic when nearly half of the women resume sexual
intercourse within six weeks of giving birth, regardless of
lactation or delivery method [18]. As such, a delay in effective
modern contraceptive method initiation can be detrimental
for women of low income or with high-risk pregnancies.
Focused contraceptive counseling and education by
health providers is essential to improve women’s reproductive
health and postnatal care. In a qualitative study comprised
of postpartum, urban, and minority women, participants
showed preference for frequent contraceptive counseling
sessions throughout pregnancy, with reinforcement and
reevaluation of decisions after delivery [22]. Thus, public
health strategies seeking to reduce high rates of unintended
pregnancies should include the postpartum period since
women’s opinions of subsequent pregnancies change over
time [10] and the PPCV is already an important standard of
care for postpartum women.
This study was strengthened by the use of claims data
rather than self-report data to ensure more objective measures of key variables of interest such as contraception
and PPCV. We also considered a myriad of factors that
could affect women’s use of contraception or attendance
such as sociodemographic characteristics, health behaviors,
history of depression, and pregnancy/birth outcomes. The
focus on a high-risk population receiving publicly funded

In conclusion, among women with Medicaid, those who
attended a postpartum visit were 50% more likely to use a
modern contraceptive method after delivery. The postpartum
visit is an apt setting for health providers to educate women
on family planning options to ensure proper birth spacing
and prevent unintended or rapid repeat pregnancies. Reducing barriers for access to and use of PPCV is greatly needed
in low-income women or other vulnerable populations who
face additional challenges with unstable housing, transportation barriers, and language barriers [24]. Future studies are
needed to evaluate effective components of care (e.g., multiple
counseling sessions) and patient-provider communication.
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